Endothelial Protein C Receptor-Dependent Inhibition of Migration of Human Lymphocytes by Protein C Involves Epidermal Growth Factor Receptor1

The protein C pathway is an important regulator of the blood coagulation system. Protein C may also play a role in inflammatory and immunomodulatory processes. Whether protein C or activated protein C affects lymphocyte migration and possible mechanisms involved was tested. Lymphocyte migration was studied by micropore filter assays. Lymphocytes that were pretreated with protein C (Ceprotin) or activated protein C (Xigris) significantly reduced their migration toward IL-8, RANTES, MCP-1, and substance P, but not toward sphingosine-1-phosphate. The inhibitory effects of protein C or activated protein C were reversed by Abs against endothelial protein C receptor and epidermal growth factor receptor. Evidence for the synthesis of endothelial protein C receptor by lymphocytes is shown by demonstration of receptor mRNA expression and detection of endothelial protein C receptor immunoreactivity on the cells’ surface. Data suggest that an endothelial protein C receptor is expressed by lymphocytes whose activation with protein C or activated protein C arrests directed migration. Exposure of lymphocytes to protein C or activated protein C stimulates phosphorylation of Tyr845 of epidermal growth factor receptor, which may be relevant for cytoprotective effects of the protein C pathway.

[1]  C. Feistritzer,et al.  Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. , 2005, Blood.

[2]  B. Lambrecht,et al.  Activated protein C inhibits bronchial hyperresponsiveness and Th2 cytokine expression in mice. , 2004, Blood.

[3]  José A Fernández,et al.  Activated Protein C Prevents Neuronal Apoptosis via Protease Activated Receptors 1 and 3 , 2004, Neuron.

[4]  T. Malek,et al.  The main function of IL‐2 is to promote the development of T regulatory cells , 2003, Journal of leukocyte biology.

[5]  W. Ruf,et al.  Activated protein C signals through the thrombin receptor PAR1 in endothelial cells , 2003, Journal of endotoxin research.

[6]  K. Fukudome,et al.  Expression and function of the endothelial protein C receptor in human neutrophils. , 2003, Blood.

[7]  C. Feistritzer,et al.  Endothelial protein C receptor-dependent inhibition of human eosinophil chemotaxis by protein C. , 2003, The Journal of allergy and clinical immunology.

[8]  J. Griffin,et al.  Inhibition of staurosporine-induced apoptosis of endothelial cells by activated protein C requires protease-activated receptor-1 and endothelial cell protein C receptor. , 2003, The Biochemical journal.

[9]  B. Dahlbäck,et al.  Gla domain-mutated human protein C exhibiting enhanced anticoagulant activity and increased phospholipid binding. , 2003, Blood.

[10]  José A Fernández,et al.  Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective , 2003, Nature Medicine.

[11]  E. Goetzl,et al.  Cutting Edge: Suppression of T Cell Chemotaxis by Sphingosine 1-Phosphate1 , 2002, The Journal of Immunology.

[12]  W. Ruf,et al.  Science review: Role of coagulation protease cascades in sepsis , 2002, Critical care.

[13]  W. Ruf,et al.  Activation of Endothelial Cell Protease Activated Receptor 1 by the Protein C Pathway , 2002, Science.

[14]  R. Bar-Shavit,et al.  Signalling pathways induced by protease‐activated receptors and integrins in T cells , 2002, Immunology.

[15]  C. Esmon.  Protein C pathway in sepsis , 2002, Annals of medicine.

[16]  K. Hokamp,et al.  Characterization of protein C receptor expression in monocytes , 2001, British journal of haematology.

[17]  S. Coughlin.  Protease-activated Receptors in Vascular Biology , 2001, Thrombosis and Haemostasis.

[18]  J. Dhainaut,et al.  Activated protein C versus protein C in severe sepsis , 2001, Critical care medicine.

[19]  L. Gelbert,et al.  Gene Expression Profile of Antithrombotic Protein C Defines New Mechanisms Modulating Inflammation and Apoptosis* , 2001, The Journal of Biological Chemistry.

[20]  J Ean,et al.  Efficacy and safety of recombinant human activated protein C for severe sepsis. , 2001, The New England journal of medicine.

[21]  A. Pucci,et al.  Thrombin regulates the expression of proangiogenic cytokines via proteolytic activation of protease-activated receptor-1. , 2000, General pharmacology.

[22]  J. Bernhagen,et al.  Activated protein C inhibits tumor necrosis factor and macrophage migration inhibitory factor production in monocytes. , 2000, European cytokine network.

[23]  D. O’Toole,et al.  Activated protein C inhibits lipopolysaccharide‐induced nuclear translocation of nuclear factor κB (NF‐κB) and tumour necrosis factor α (TNF‐α) production in the THP‐1 monocytic cell line , 2000, British journal of haematology.

[24]  P. Babál,et al.  Interactions between agmatine and polyamine uptake pathways in rat pulmonary artery endothelial cells. , 2000, General pharmacology.

[25]  K. Fukudome,et al.  The endothelial cell protein C receptor (EPCR) functions as a primary receptor for protein C activation on endothelial cells in arteries, veins, and capillaries. , 1999, Biochemical and biophysical research communications.

[26]  A. Ullrich,et al.  Epidermal growth factor receptors: critical mediators of multiple receptor pathways. , 1999, Current opinion in cell biology.

[27]  S. Coughlin.  Sol Sherry lecture in thrombosis: how thrombin 'talks' to cells: molecular mechanisms and roles in vivo. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[28]  A. Ullrich,et al.  Signal characteristics of G protein‐transactivated EGF receptor , 1997, The EMBO journal.

[29]  C. Esmon,et al.  The Interaction between the Endothelial Cell Protein C Receptor and Protein C Is Dictated by the γ-Carboxyglutamic Acid Domain of Protein C* , 1997, The Journal of Biological Chemistry.

[30]  K. Takatsuki,et al.  Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production. , 1997, The American journal of physiology.

[31]  C. Esmon,et al.  The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[32]  C. Esmon,et al.  The Endothelial Cell Protein C Receptor , 1996, The Journal of Biological Chemistry.

[33]  S. Grey,et al.  A physiologic anti-inflammatory pathway based on thrombomodulin expression and generation of activated protein C by human mononuclear phagocytes. , 1996, Journal of immunology.

[34]  A. Ullrich,et al.  Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors , 1996, Nature.

[35]  K. Takatsuki,et al.  Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats. , 1996, Blood.

[36]  L. Medved,et al.  Thermal Stability and Domain-Domain Interactions in Natural and Recombinant Protein C (*) , 1995, The Journal of Biological Chemistry.

[37]  S. Hubbard,et al.  Crystal structure of the tyrosine kinase domain of the human insulin receptor , 1994, Nature.

[38]  Jonathan A. Cooper,et al.  The when and how of Src regulation , 1993, Cell.

[39]  C. Esmon,et al.  The function of calcium in protein C activation by thrombin and the thrombin-thrombomodulin complex can be distinguished by mutational analysis of protein C derivatives. , 1992, The Journal of biological chemistry.

[40]  V. Wheaton,et al.  Characterization of a functional thrombin receptor. Issues and opportunities. , 1992, The Journal of clinical investigation.

[41]  C. Esmon,et al.  Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[42]  A. Ullrich,et al.  EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF , 1999, Nature.

[43]  Sheila M. Thomas,et al.  Cellular functions regulated by Src family kinases. , 1997, Annual review of cell and developmental biology.